265
Views
8
CrossRef citations to date
0
Altmetric
Editorial

The safety of atypical antipsychotics: does QTc provide all the answers?

Pages 341-344 | Published online: 20 Apr 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Christoffer Polcwiartek, Kristian Kragholm, Ole Schjerning, Claus Graff & Jimmi Nielsen. (2016) Cardiovascular safety of antipsychotics: a clinical overview. Expert Opinion on Drug Safety 15:5, pages 679-688.
Read now
Danielle S Cha & Roger S McIntyre. (2012) Treatment-emergent adverse events associated with atypical antipsychotics. Expert Opinion on Pharmacotherapy 13:11, pages 1587-1598.
Read now

Articles from other publishers (6)

Annamaria Mascolo, Cristina Scavone, Concetta Rafaniello & A. Capuano. 2020. Brain and Heart Dynamics. Brain and Heart Dynamics 721 729 .
A. Mascolo, C. Scavone, C. Rafaniello & A. Capuano. 2019. Brain and Heart Dynamics. Brain and Heart Dynamics 1 10 .
Christoffer Polcwiartek, Benjamin Sneider, Claus Graff, David Taylor, Jonathan Meyer, Jørgen K. Kanters & Jimmi Nielsen. (2015) The cardiac safety of aripiprazole treatment in patients at high risk for torsade: a systematic review with a meta-analytic approach. Psychopharmacology 232:18, pages 3297-3308.
Crossref
J. Nielsen, R. Roge, S. G. Pristed, A. G. Viuff, H. Ullum, L. W. Thorner, T. Werge & T. Vang. (2014) Soluble Urokinase-Type Plasminogen Activator Receptor Levels in Patients With Schizophrenia. Schizophrenia Bulletin 41:3, pages 764-771.
Crossref
Jimmi Nielsen, Fan Wang, Claus Graff & Jørgen K. Kanters. (2014) QT dynamics during treatment with sertindole. Therapeutic Advances in Psychopharmacology 5:1, pages 26-31.
Crossref
Jimmi Nielsen, Claus Graff, Jørgen K. Kanters, Egon Toft, David Taylor & Jonathan M. Meyer. (2011) Assessing QT Interval Prolongation and its Associated Risks with Antipsychotics. CNS Drugs 25:6, pages 473-490.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.